FDA
-
-
-
-
-
-
-
BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission
-
-
-
-
-
-
-
BioCardia receives FDA confirmation for CardiAMP trial pathway
-
-
-
-
-
-
-
BioCardia receives FDA guidance on two approval pathways for Helix catheter
-
-
-
-
-
-
-
BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure
-
-
-
-
-
-
-
BioCardia Announces Late Breaking Echocardiography Results from the CardiAMP HF Trial to be Presented at Technology and Heart Failure Therapeutics (THT)
-
-
-
-
-
-
-
BioCardia enrolls first patient at University of Wisconsin in phase 3 trial
-
-
-
-
-
-
-
BioCardia outlines regulatory timeline for heart therapy approvals
-
335,369 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


